HPR24 Analysis of Historical European Medicines Agency (EMA) Marketing Authorization (MA) Timelines: Will EU Joint Clinical Assessment (JCA) Timelines Be Longer Than Expected?
Dec 1, 2025, 00:00
10.1016/j.jval.2025.09.1434
https://www.valueinhealthjournal.com/article/S1098-3015(25)03991-9/fulltext
Title :
HPR24 Analysis of Historical European Medicines Agency (EMA) Marketing Authorization (MA) Timelines: Will EU Joint Clinical Assessment (JCA) Timelines Be Longer Than Expected?
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(25)03991-9&doi=10.1016/j.jval.2025.09.1434
First page :
Section Title :
Open access? :
No
Section Order :
10975